The below was received this morning. This wasn’t commissioned or paid for by the company. Important distinction compared to the typical conflicted paid Research-as-a-Service report many publish. Also worth noting some interesting U.S. buying and holders followed their initiation. Here's hoping that continues.
Jones Research updated with price target of $0.75
Radiopharm Theranostics (ASX:RAD), a developer of a world-class platform of radiopharmaceutical products for both diagnostic and therapeutic uses, is pleased to provide an updated research report from Jones Research.
Click below to view the full report:
Jones Research updated with price target of $0.75
Add RAD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.2¢ |
Change
0.001(2.44%) |
Mkt cap ! $18.97M | |||
| Open | High | Low | Value | Volume |
| 4.1¢ | 4.2¢ | 4.1¢ | $3.33K | 80.89K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 3.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.2¢ | 16788 | 1 |
View Market Depth
| Last trade - 16.10pm 07/05/2024 (20 minute delay) ? |
|
|||||
|
Last
4.1¢ |
Change
0.001 ( 2.50 %) |
||||
| Open | High | Low | Volume | ||
| 4.1¢ | 4.1¢ | 4.1¢ | 53930 | ||
| Last updated 15.40pm 07/05/2024 ? | |||||
| RAD (ASX) Chart |